Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Templin

Showing results (861-870 of 888) with videos related to

Pageof 89
Sort By:
Scientific Reports|June 26, 2026
Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMIPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
European Journal of Human Genetics : EJHG|July 24, 2014
Baraitser-Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 casesAlain Verloes, Nataliya Di Donato, Julien Masliah-Planchon, et al.
Molecular Therapy. Advances|May 18, 2026
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulationGhazaleh Zarrinrad, Lisa-Marie Burkhardt, Claudia Beltran-Mestres, et al.
American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
American Journal of Human Genetics|March 5, 2013
Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromesMaria Delio, Tingwei Guo, Donna M McDonald-McGinn, et al.
American Heart Journal|April 10, 2025
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trialHans-Josef Feistritzer, Alexander Jobs, Uwe Zeymer, et al.
The New England Journal of Medicine|September 3, 2015
Clinical Features and Outcomes of Takotsubo (Stress) CardiomyopathyChristian Templin, Jelena R Ghadri, Johanna Diekmann, et al.
Journal of the American Heart Association|July 18, 2019
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo RegistryVictoria L Cammann, Annahita Sarcon, Katharina J Ding, et al.
Pageof 89

Showing results (861-870 of 888) with videos related to

Sort By:
Pageof 89
Scientific Reports|June 26, 2026
Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMIPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
European Journal of Human Genetics : EJHG|July 24, 2014
Baraitser-Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 casesAlain Verloes, Nataliya Di Donato, Julien Masliah-Planchon, et al.
Molecular Therapy. Advances|May 18, 2026
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulationGhazaleh Zarrinrad, Lisa-Marie Burkhardt, Claudia Beltran-Mestres, et al.
American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
American Journal of Human Genetics|March 5, 2013
Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromesMaria Delio, Tingwei Guo, Donna M McDonald-McGinn, et al.
American Heart Journal|April 10, 2025
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trialHans-Josef Feistritzer, Alexander Jobs, Uwe Zeymer, et al.
The New England Journal of Medicine|September 3, 2015
Clinical Features and Outcomes of Takotsubo (Stress) CardiomyopathyChristian Templin, Jelena R Ghadri, Johanna Diekmann, et al.
Journal of the American Heart Association|July 18, 2019
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo RegistryVictoria L Cammann, Annahita Sarcon, Katharina J Ding, et al.
Pageof 89